Press
-
Featured innovator: Nathan Collins
Nathan Collins, former CSO of SRI Biosciences discusses current and future plans for leveraging AI to help advance modern chemistry and SRI’s related work in the biosciences industry
-
75 Years of Innovation: FOX Three Molecular Guidance System
How the FOX Three Molecular Guidance System helps large drugs cross barriers
-
Developing the next generation of PCR diagnostics for point-of-contact screening
SRI International investigator awarded National Science Foundation grant for development of a revolutionary point of contact diagnostic for infectious diseases The current world-wide COVID-19 pandemic underscores the need for rapid and widespread screening for emerging infectious agents. As emerging infectious diseases can spread rapidly, government agencies have made developing detection technologies a priority. To explore…
-
Hope for struggling readers — early evidence from the use of augmented reality
Research from a team of SRI education researchers explored how augmented reality (AR) and virtual reality (VR) have the potential to complement what special education educators do for students with dyslexia
-
Nathan Collins talks about how the SynFini automated chemistry platform is accelerating drug development and discovery.
Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: www.sri.com/case-studies/synfini/
-
Nathan Collins talks about the SynFini™ automated chemistry platform (Part 1)
Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: https://www.sri.com/case-studies/synfini. Nathan Collins is the Chief Strategy Officer of SRI Biosciences in Menlo Park, CA. In part one of this episode of The Dish TV they discuss the processes and problems of new drug discovery…
-
Nathan Collins talks about integrating AI with the SynFini™ Platform (Part 2)
Nathan Collins discusses how integrating AI with the SynFini automated chemistry platform is poised to shape the future of drug discovery and development. Learn more about SynFini at: https://www.sri.com/case-studies/synfini Nathan Collins is the Chief Strategy Officer of SRI Biosciences in Menlo Park, CA. In part two of this episode of The Dish TV they discuss…
-
75 Years of Innovation: Centibots
The hive mind of robots
-
How can we win against emerging viruses?
Every virus is different — but by finding small similarities in their genomes, we can develop treatments that will make us more prepared for future outbreaks
-
75 Years of Innovation: LED, first blue-light emitting diode
Red, yellow, blue for GO! How the LED got its blue glow
-
Decoded Health — How a Virtual Medical Resident Can Help Physicians During and After the Coronavirus Emergency
The coronavirus has swept the planet, taking a toll on our health and wealth. The pandemic is hitting every continent and putting strain on our critical infrastructures. Healthcare, under pressure at the best of times, is having to take the brunt of COVID-19.
-
75 Years of Innovation: The Computer Mouse
A major development in Human-Computer Interaction (HCI) driving the advent of more accessible and controllable consumer computers.